Terms: = Gastric cancer AND ELK4, SAP1, 2005, ENSG00000158711, P28324 AND Treatment
571 results:
1. The Clinical Impact of the Prognostic Immune and Nutritional Index in gastric cancer Patients Who Received Curative treatment.
Aoyama T; Hashimoto I; Maezawa Y; Hara K; Tamagawa A; Cho H; Morita J; Tanabe M; Numata M; Kawahara S; Oshima T; Saito A; Yukawa N
Anticancer Res; 2024 May; 44(5):2231-2238. PubMed ID: 38677750
[TBL] [Abstract] [Full Text] [Related]
2. Clinical Impact of the Lymphocyte-to-Monocyte Ratio in Patients With gastric cancer who Received Curative treatment.
Aoyama T; Hashimoto I; Maezawa Y; Hara K; Tamagawa A; Cho H; Numata M; Morita J; Tanabe M; Kawahara S; Oshima T; Saito A; Yukawa N; Rino Y
Anticancer Res; 2024 Apr; 44(4):1567-1574. PubMed ID: 38537996
[TBL] [Abstract] [Full Text] [Related]
3. The CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for gastric cancer Patients who Receive Curative treatment.
Aoyama T; Maezawa Y; Hashimoto I; Hara K; Tamagawa A; Kazama K; Kato A; Cho H; Nakazono M; Numata M; Kawahara S; Tanabe M; Morita J; Oshima T; Saito A; Yukawa N; Rino Y
Anticancer Res; 2024 Apr; 44(4):1629-1636. PubMed ID: 38537973
[TBL] [Abstract] [Full Text] [Related]
4. The Naples Prognostic Score Is an Independent Prognostic Factor for gastric cancer Patients Who Receive Curative treatment.
Aoyama T; Kato A; Hashimoto I; Maezawa Y; Hara K; Kazama K; Komori K; Tamagawa H; Tamagawa A; Nagasawa S; Cho H; Segami K; Nakazono M; Otani K; Sawazaki S; Numata M; Kamiya N; Yoshizawa S; Kawahara S; Oshima T; Saito A; Yukawa N; Rino Y
In Vivo; 2024; 38(2):890-896. PubMed ID: 38418121
[TBL] [Abstract] [Full Text] [Related]
5. The Clinical Influence of Geriatric Nutritional Risk Index in Patients With gastric cancer Who Receive Curative treatment.
Aoyama T; Maezawa Y; Hashimoto I; Hara K; Kazama K; Numata M; Sawazaki S; Tamagawa H; Tamagawa A; Nakazono M; Segami K; Cho H; Tateishi M; Minami T; Nagasawa S; Komori K; Kato A; Otani K; Kawahara S; Oshima T; Yukawa N; Saito A; Rino Y
Anticancer Res; 2023 Dec; 43(12):5605-5612. PubMed ID: 38030197
[TBL] [Abstract] [Full Text] [Related]
6. Trends in gastric cancer mortality 2005-2020 in Peru and its geographical areas: A joinpoint regression analysis.
Smith Torres-Roman J; Julca-Marín D; Ticona-Tiña D; Quispe-Vicuña C; Bazalar-Palacios J; De La Cruz-Ku G; Ybaseta-Medina J
Cancer Epidemiol; 2023 Dec; 87():102485. PubMed ID: 37976631
[TBL] [Abstract] [Full Text] [Related]
7. High incidence of antibiotic resistance amongst isolates of
Garvey E; Rhead J; Suffian S; Whiley D; Mahmood F; Bakshi N; Letley D; White J; Atherton J; Winter JA; Robinson K
J Med Microbiol; 2023 Nov; 72(11):. PubMed ID: 37962209
[No Abstract] [Full Text] [Related]
8. The Clinical Impact of the Pretreatment Platelet-to-Lymphocyte Ratio in gastric cancer Patients Who Receive Curative treatment.
Aoyama T; Hashimoto I; Maezawa Y; Hara K; Kazama K; Numata M; Kamiya N; Tamagawa H; Sawazaki S; Kawahara S; Komori K; Tamagawa A; Cho H; Morita J; Otani K; Kato A; Tanabe M; Oshima T; Yukawa N; Saito A; Rino Y
In Vivo; 2023; 37(6):2696-2703. PubMed ID: 37905661
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological study of gastric cancer in a Malaysian tertiary public health care centre.
Htet H; Win TT; Wong ST; Shamsudin NH; Kandasami P
Med J Malaysia; 2023 Sep; 78(5):616-620. PubMed ID: 37775488
[TBL] [Abstract] [Full Text] [Related]
10. Cardiorespiratory fitness and BMI measured in youth and 5-year mortality after site-specific cancer diagnoses in men-A population-based cohort study with register linkage.
Onerup A; Mehlig K; Ekblom-Bak E; Lissner L; Börjesson M; Åberg M
Cancer Med; 2023 Oct; 12(19):20000-20014. PubMed ID: 37732468
[TBL] [Abstract] [Full Text] [Related]
11. Validity of Endoscopic Submucosal Dissection for gastric cancer Diagnosed as Differentiated Adenocarcinoma Before treatment Regardless of Lesion Size.
Nomura K; Hoteya S; Ochiai Y; Okamura T; Suzuki Y; Hayasaka J; Mitsunaga Y; Tanaka M; Fuchinoue K; Odagiri H; Yamashita S; Matsui A; Kikuchi D
Turk J Gastroenterol; 2023 Nov; 34(11):XXXX. PubMed ID: 37681270
[TBL] [Abstract] [Full Text] [Related]
12. Clinical characteristics and prognostic outcomes for adenocarcinoma of esophagogastric junction in early-onset patients: a population-based appraisal.
Lai H; Zheng J; Zhou G; Li Y
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14941-14952. PubMed ID: 37606763
[TBL] [Abstract] [Full Text] [Related]
13. Randomized controlled trial in gastric or gastroesophageal junction adenocarcinoma undergoing systemic therapy over two decades.
Xu BB; Lu J; Zheng HL; Xue Z; Zheng CH; Li P; Chen QY; Xie JW; Huang CM
Eur J Surg Oncol; 2023 Oct; 49(10):107007. PubMed ID: 37591026
[TBL] [Abstract] [Full Text] [Related]
14. [Prognostic value of a predictive model comprising preoperative inflammatory response and nutritional indexes in patients with gastric cancer].
Wu LL; Cai MZ; Wang BG; Deng JY; Ke B; Zhang RP; Liang H; Wang XN
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jul; 26(7):680-688. PubMed ID: 37583026
[No Abstract] [Full Text] [Related]
15. Acceleration of sarcopenia in elderly patients who develop asymptomatic pneumonia shadow within one year after surgery for early gastric cancer.
Kamiya A; Hayashi T; Sakon R; Ishizu K; Wada T; Otsuki S; Yamagata Y; Katai H; Yoshikawa T
BMC Surg; 2023 Aug; 23(1):232. PubMed ID: 37568129
[TBL] [Abstract] [Full Text] [Related]
16. Evaluation of Nationwide Trends in Nodal Sampling Guideline Adherence for gastric cancer: 2005-2017.
Mahenthiran AK; Logan CD; Janczewski LM; Valukas C; Warwar S; Silver CM; Feinglass J; Merkow RP; Bentrem DJ; Odell DD
J Surg Res; 2023 Nov; 291():514-526. PubMed ID: 37540969
[TBL] [Abstract] [Full Text] [Related]
17. Noninvasive imaging evaluation of peritoneal recurrence and chemotherapy benefit in gastric cancer after gastrectomy: a multicenter study.
Sun Z; Wang W; Huang W; Zhang T; Chen C; Yuan Q; Chen Y; Zhou K; Han Z; Feng H; Chen H; Liang X; Hu Y; Yu J; Liu H; Yu L; Xu Y; Li G; Jiang Y
Int J Surg; 2023 Jul; 109(7):2010-2024. PubMed ID: 37300884
[TBL] [Abstract] [Full Text] [Related]
18. External Validation of the eCura System for Undifferentiated-Type Early gastric cancer with Noncurative Endoscopic Resection.
Yang HJ; Kim YI; Ahn JY; Choi KD; Kim SG; Jeon SW; Kim JH; Shin SK; Lee H; Lee WS; Kim GH; Park JM; Shin WG; Choi IJ
Gut Liver; 2023 Jul; 17(4):537-546. PubMed ID: 37161698
[TBL] [Abstract] [Full Text] [Related]
19. Endoscopic resection of early esophageal tumors in patients with cirrhosis or portal hypertension: a multicenter observational study.
Simonnot M; Deprez PH; Pioche M; Albuisson E; Wallenhorst T; Caillol F; Koch S; Coron E; Archambeaud I; Jacques J; Basile P; Caillo L; Degand T; Lepilliez V; Grandval P; Culetto A; Vanbiervliet G; Camus Duboc M; Gronier O; Leal C; Albouys J; Chevaux JB; Barret M; Schaefer M
Endoscopy; 2023 Sep; 55(9):785-795. PubMed ID: 37137331
[TBL] [Abstract] [Full Text] [Related]
20. Outcome and patterns of relapse in primary gastric diffuse large B cell lymphoma treated with RCHOP.
Ma'koseh M; Farfoura H; Abufara A; Elmusa R; Hushki A; Faqeer N; Ghatasheh H; Shahin O; Alawabdeh T; Al-Rwashdeh M; Halahleh K; Al-Ibraheem A; Alrabi K
Hematology; 2023 Dec; 28(1):2198898. PubMed ID: 37114663
[TBL] [Abstract] [Full Text] [Related]
[Next]
